000 01318 a2200349 4500
005 20250515232217.0
264 0 _c20101130
008 201011s 0 0 eng d
022 _a1768-3254
024 7 _a10.1016/j.ejmech.2010.04.034
_2doi
040 _aNLM
_beng
_cNLM
100 1 _ade Oliveira, André N
245 0 0 _aNew substituted 4-arylaminoquinazolines as potent inhibitors of breast tumor cell lines: in vitro and docking experiments.
_h[electronic resource]
260 _bEuropean journal of medicinal chemistry
_cSep 2010
300 _a4339-42 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBreast Neoplasms
_xpathology
650 0 4 _aCell Line, Tumor
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aModels, Molecular
650 0 4 _aProtein Conformation
650 0 4 _aQuinazolines
_xchemical synthesis
700 1 _aBocca, Cleverson C
700 1 _aCarvalho, João E
700 1 _aRuiz, Ana Lúcia G
700 1 _aSilva, Thiago P
700 1 _aRittner, Roberto
700 1 _aHoehr, Nelci F
773 0 _tEuropean journal of medicinal chemistry
_gvol. 45
_gno. 9
_gp. 4339-42
856 4 0 _uhttps://doi.org/10.1016/j.ejmech.2010.04.034
_zAvailable from publisher's website
999 _c19970315
_d19970315